WebDisclosure WebDisclosure
Basculer en Français
10052 Companies
205146 Keywords
135404 Articles
108776 Press releases
Headlines Articles Press releases Moderna, Inc. Remove
  1. Home
  2. Companies
  3. Moderna, Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/30/2023 at 13:15, 3 years 1 month ago

    Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate

    Logo of Moderna, Inc.
  • PRESS RELEASE

    published on 01/17/2023 at 22:05, 3 years 2 months ago

    Moderna Announces mRNA-1345, an Investigational Respiratory Syncytial Virus (RSV) Vaccine, Has Met Primary Efficacy Endpoints in Phase 3 Trial in Older Adults

    Logo of Moderna, Inc.
  • PRESS RELEASE

    published on 01/09/2023 at 13:00, 3 years 2 months ago

    Moderna Announces Advances Across mRNA Pipeline and Provides Business Update

    Logo of Moderna, Inc.
  • PRESS RELEASE

    published on 01/05/2023 at 22:05, 3 years 2 months ago

    Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics

    Logo of Moderna, Inc.
Previous page
1 ... 33 34
Accesswire
  • Published on 03/19/2026 at 07:30, 19 minutes ago

    Tocvan Drone Magnetic Data Strengthens Gold-Silver Targets Across Gran Pilar; Identifies Broad Zones for Expansion Potential

  • Published on 03/19/2026 at 06:35, 1 hour 14 minutes ago

    Golden Lake Announces Securityholder Approval of Arrangement with McEwen Inc.

  • Published on 03/19/2026 at 01:05, 6 hours 44 minutes ago

    Prospect Ridge Announces Closing of Flow-Through Share Private Placement

  • Published on 03/18/2026 at 23:45, 8 hours 4 minutes ago

    Orogen Royalties Announces Private Placement Update

  • Published on 03/18/2026 at 21:00, 10 hours 49 minutes ago

    PLDT's Smart Selects Amdocs to Transform Retail Operations with AI-Powered Store Genie

View all ACCESSWIRE
EQS Group
  • Published on 03/19/2026 at 07:35, 14 minutes ago

    Lenzing advances its transformation: Higher EBITDA, stronger free cash flow and more than EUR 200 million in cost savings

  • Published on 03/19/2026 at 07:30, 19 minutes ago

    Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

  • Published on 03/19/2026 at 07:30, 19 minutes ago

    The Nordex Group receives orders totaling 54 MW from Prowind in Germany

  • Published on 03/19/2026 at 07:30, 19 minutes ago

    Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation

  • Published on 03/19/2026 at 07:30, 19 minutes ago

    SGL Carbon: Restructuring ensures earnings forecast and creates basis for new growth

View all EQS
Les Echos
  • Published on 03/19/2026 at 07:00, 49 minutes ago

    bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe

  • Published on 03/19/2026 at 07:00, 49 minutes ago

    bioMérieux obtient le marquage CE IVDR pour deux tests BIOFIRE® SPOTFIRE® afin de renforcer en Europe le diagnostic des infections respiratoires et pharyngées au plus près du patient

  • Published on 03/19/2026 at 07:00, 49 minutes ago

    Résultats annuels 2025 et nouvelle signature stratégique

  • Published on 03/19/2026 at 07:00, 49 minutes ago

    2025 Annual results and new strategic signature

  • Published on 03/18/2026 at 19:41, 12 hours 8 minutes ago

    Covivio - Conditions of availability of the 2025 Universal Registration Document

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy